Ask AI
ProCE Banner Activity

Guía del paciente sobre los últimos avances clínicos en nuevas terapias para la leucemia linfocítica crónica o linfoma linfocítico pequeño recidivante/refractario

PDF

Este recurso amigable para el paciente resume los hallazgos y puntos clave de cada estudio sobre leucemia linfocítica crónica o linfoma linfocítico pequeño. Estos recursos destilan cada estudio en un documento de comunicación para pacientes descargable, para preparar a los pacientes y sus proveedores de atención médica para importantes conversaciones de toma de decisiones compartidas.

Released: April 17, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Target Audience

This activity is intended for hematologists, oncologists, and other healthcare professionals caring for patients with relapsed/refractory CLL globally.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply recently presented data to clinical practice to expand treatment options and enhance outcomes for patients with relapsed/refractory CLL

  • Appraise the potential clinical implications of new data on novel targeted and cellular therapies for treatment selection and sequencing in patients with relapsed/refractory CLL

  • Support effective shared decision-making through patient education and resources on the potential clinical implications of recently presented data for relapsed/refractory CLL